| Literature DB >> 30775168 |
Uros Glavinic1, Tanja Tesovnik2, Jevrosima Stevanovic1, Minja Zorc2, Ivanka Cizelj2, Zoran Stanimirovic1, Mojca Narat2.
Abstract
Among numerous factors that contribute to honey bee colony losses and problems in beekeeping, pesticides and Nosema ceranae have been often reported. In contrast to insecticides, whose effects on bees have been widely studied, fungicides did not attract considerable attention. Prochloraz, an imidazole fungicide widely used in agriculture, was detected in honey and pollen stored inside hives and has been already proven to alter immune gene expression of honey bees at different developmental stages. The aim of this study was to simulate the realistic conditions of migratory beekeeping, where colonies, both uninfected and infected with N. ceranae, are frequently transported to the vicinity of crop fields treated with prochloraz. We investigated the combined effect of prochloraz and N. ceranae on honey bees that faced fungicide during the larval stage through food consumption and microsporidium infection afterwards. The most pronounced changes in gene expression were observed in newly emerged Nosema-free bees originating from colonies previously contaminated with prochloraz. As exclusively upregulation was registered, prochloraz alone most likely acts as a challenge that induces activation of immune pathways in newly emerged bees. The combination of both stressors (prochloraz and Nosema infection) exerted the greatest effect on six-day-old honey bees. Among ten genes with significantly altered expression, half were upregulated and half downregulated. N. ceranae as a sole stressor had the weakest effects on immune gene expression modulation with only three genes significantly dysregulated. In conclusion, food contaminated with prochloraz consumed in larval stage could present a threat to the development of immunity and detoxification mechanisms in honey bees.Entities:
Keywords: Apis mellifera; Colony loss; Gene expression; Immunity; Nosema; Prochloraz
Year: 2019 PMID: 30775168 PMCID: PMC6371917 DOI: 10.7717/peerj.6325
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Experimental design and description of experimental groups.
| Sampling | Prochloraz non-treated groups | Prochloraz treated groups | ||
|---|---|---|---|---|
| Non-infected bees (C) | Non-infected bees (P) | |||
| day 0 | C0 | / | P0 | / |
| day 6 | C6 | CN6 | P6 | PN6 |
| day 9 | C9 | CN9 | P9 | PN9 |
| day 15 | C15 | CN15 | P15 | PN15 |
Notes.
Number of days after emergence; on each sampling day seven honey bees were collected for qPCR gene expression analysis.
Infection with N. ceranae was performed on 3rd day after honey bees emergence.
Experimental group designation.
Samples were not collected.
Primers used in this study.
| Targets/Locus gene ID | Gene description | Sequences of primers used in qPCR | Efficiency (%) | |
|---|---|---|---|---|
| F: TCTGGCGGCCGGTTAAAGGCTTC | ||||
| F: TCAATTTCAGCCTTTTATTCAAGA | ||||
| ABPV | Acute bee paralysis virus isolate GFf1ab | F: ACCGACAAAGGGTATGATGC | ||
| BQCV | Black queen cell virus | F: TTTAGAGCGAATTCGGAAACA | ||
| DWV | Deformed wing virus isolate | F: GAGATTGAAGCGCATGAACA | 99.3 | 0.981 |
| IAPV | Israel acute paralysis virus of bees | F: GCGGAGAATATAAGGCTCAG | ||
| KBV | Kashmir bee virus | F: TGAACGTCGACCTATTGAAAAA | ||
| F: CGGGAGATGAGAAAACCAAT | ||||
| Actin | Actin - cytoskeletal structural protein | F: TTGTATGCCAACACTGTCCTTT | 98.1 | 0.996 |
| RPS5 | Ribosomal protein S5a | F: AATTATTTGGTCGCTGGAATTG | 101.0 | 0.989 |
| Abaecin | Abaecin, antimicrobial peptide | F: CAGCATTCGCATACGTACCA | 104.3 | 0.992 |
| Basket | JNK MAP kinase | F: AGGAGAACGTGGACATTTGG | 96.7 | 0.992 |
| Cactus | IkB transcription factor | F: CCTGGACTGTCTGGATGGTT | 98.8 | 0.979 |
| Defensin-1 | Defensin 1 | F: TGCGCTGCTAACTGTCTCAG | 101.0 | 0.983 |
| Defensin-2 | Defensin 2 | F: GCAACTACCGCCTTTACGTC | 96.4 | 0.992 |
| Domeless | Cytokine receptor; JAK-STAT immune signalling pathway | F: TTGTGCTCCTGAAAATGCTG | 104.1 | 0.997 |
| Dorsal-1 | NFkB transcription factor orthologue | F: AGAGATGGAACGCAGGAAAC | 98.7 | 0.994 |
| Hopscotch | JAK tyrosine kinase | F: ATTCATGGCATCGTGAACAA | 103.2 | 0.995 |
| Kayak | Fos, the Drosophila homologue of the mammalian proto-oncogene product c-Fos | F: CGACAGATCCGCAGAGAAAG | 98.0 | 0.988 |
| Lys2 | Lysozyme; immune system-end product | F: CCAAATTAACAGCGCCAAGT | 102.4 | 0.994 |
| PGRPSC4300 | Peptidoglycan recognition protein S1 | F: GAGGCTGGTACGACATTGGT | 104.6 | 0.996 |
| Spaetzle | Toll-binding cytokine-like molecule | F: TGCACAAATTGTTTTTCCTGA | 101.1 | 0.973 |
| Toll | Toll-like receptor | F: TAGAGTGGCGCATTGTCAAG | 100.1 | 0.987 |
| PKA-C1 | cAMP-dependent protein kinase 1 | F: TCCATTTTTGGTCTCCTTGC | 98.1 | 0.998 |
| PKA-R1 | cAMP-dependent protein kinase type I regulatory subunit | F: GAAGCAATTATTCGGCAAGG | 99.3 | 0.992 |
Figure 1Treatment depended statistical analysis box plot diagram for immune–related and detoxification gene expression.
Each box plot represents the ΔCq values measured for biological replicates for selected treatment. Boxes marked with an asterisk show statistically significant effects of treatment on gene expression when the p-value was equal or less than 0.05. If there were no significant differences among the groups, they share the same color. Treatments are indicated in the scale at the bottom of the plots (Control, C; Nosema-infected, CN; Prochloraz-treated, P; Prochloraz treated and Nosema-infected, PN). Analysis was undertaken with program R.
Figure 2Treatment depended statistical analysis box plot diagram for gene expression of antimicrobial peptides.
Each box plot represents the ΔCq values measured for biological replicates for selected treatment. Boxes marked with an asterisk show statistically significant effects of treatment on gene expression when the p-value was equal or less than 0.05. If there were no significant differences among the groups, they share the same color. Treatments are indicated in the scale at the bottom of the plots (Control, C; Nosema-infected, CN; Prochloraz-treated, P; Prochloraz treated and Nosema-infected, PN). Analysis was undertaken with program R.
Figure 3Heatmap immune-related genes in adult honey bee at different ages (0-, 6-, 9- and 15-days after honey bee emergence).
The colors indicate the average mRNA levels compared to average levels of mRNA in control groups: blue indicate lower and yellow higher levels. Range log2 value of relative expression ratio is indicated in the legend on the right. Each row corresponds to one gene transcript and each column, to the expression profile of treatment. The gene names and corresponding pathway are indicated on left side. Treatments are indicated in the scale at the bottom of the graph (Nosema-infected, CN; Prochloraz-treated, P; Prochloraz treated and Nosema-infected, PN). Control group (C) was used for normalization. Boxes marked with an asterisk show statistically significant effects of the treatment on gene expression, when p-value was equal or less than 0.05.
Figure 4Deformed Wings Virus RNA loads in honey bees.
Cq: qPCR signal for pathogen loads.